Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients (Q63594223)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients
clinical trial

    Statements

    DEFENCE (English)
    0 references
    Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients- a Randomized, Placebo Controlled Phase II Trial "DEFENCE" (DEnosumab For the rEductioN of the Smoldering Myeloma transformatioN inCidence ratE) (English)
    0 references
    0 references
    January 2019
    0 references
    July 2024
    0 references
    164
    0 references
    18 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit